Page 22 - Addiction Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Achieve Life Sciences, Inc.: Achieve Announces Publication of the ORCA-1 Phase 2b Clinical Trial of Cytisinicline in Adult Smokers in Nicotine and Tobacco Research Phase 3 ORCA-2 Trial Currently Enrolling at 16 sites in United States SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / April 14, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced publication of the results from the Phase 2b ORCA-1 trial in the scientific journa...

>> reporter: the 40-year-old california man died from what health officials there called severe pulmonary injury. it's the seventh death, together with hundreds of illnesses recently linked to vaping. the cdc is investigating 380 cases across 36 states and has activated its emergency operation center, directing more staff and resources to the problem. while health experts and parents increasingly ask the same question, how can kids kick the habit. >> nicotine is one of the most addictive substances known to man. >> reporter: dr. sharon levy runs an addiction program for children. >> vaping can...

Truly addicted to these medications or addicted to heroin and we really just needed to treat them rather than put them in jail or treat them like addicts, we just wanted to treat them like normal people. >> so when you treat them like normal people, what does that entail dr. de vivine? >> in our waiting room you can't tell who is there for what. we run a family prak sctice cli. we don't look at addiction as a different problem from anything else. i think the patients find that comforting. they're treated like everyone else, they're treated with respect, and i they kept these patients in our pr...